Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson’s disease

References

• Wood-Kaczmar A, Gandhi S, Wood NW. Understanding the molecular causes of Parkinson’s disease. Trends Mol Med. 2006;12(11):521–8. doi: 10.1016/j.molmed.2006.09.007
   PubMed Web of Science ®Google Scholar
• Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med. 2003;348(14):1356–64. doi: 10.1056/NEJM2003ra020003
   PubMed Web of Science ®Google Scholar
• de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–35. doi: 10.1016/S1474-4422(06)70471-9
   PubMed Web of Science ®Google Scholar
• Forno LS. Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol. 1996;55(3):259–72. doi: 10.1097/00005072-199603000-00001
   PubMed Web of Science ®Google Scholar
• Prabhu B, et al. Neuroprotective effect of peanut hairy root extract against oxidative stress in PC12 derived neurons. Journal of Medicinally Active Plants. J Med Act Plants. 2013;1(4):125–133.
   Google Scholar
• Charradi K, Elkahoui S, Karkouch I, Limam F, Hassine FB, Aouani E. Grape seed and skin extract prevents high-fat diet-induced brain lipotoxicity in rat. Neurochem Res. 2012;37(9):2004–13. doi: 10.1007/s11064-012-0821-2
   PubMed Web of Science ®Google Scholar
• Park JS, Park M-K, Oh H-J, Woo Y-J, Lim M-A, Lee J-H, et al. Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis. PLoS One. 2012;7(12):e51377. doi: 10.1371/journal.pone.0051377
   PubMed Web of Science ®Google Scholar
• Sharma SD, Katiyar SK. Dietary grape seed proanthocyanidins inhibit UVB-induced cyclooxygenase-2 expression and other inflammatory mediators in UVB-exposed skin and skin tumors of SKH-1 hairless mice. Pharm Res. 2010;27(6):1092–102. doi: 10.1007/s11095-010-0050-9
   PubMed Web of Science ®Google Scholar
• Uchino R, Madhyastha R, Madhyastha H, Dhungana S, Nakajima Y, Omura S, et al. NFkappaB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells. Blood Coagul Fibrinolysis. 2010;21(6):528–33. doi: 10.1097/MBC.0b013e32833a9b61
   PubMed Web of Science ®Google Scholar
• Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol. 2006;545(1):51–64. doi: 10.1016/j.ejphar.2006.06.025
   PubMed Web of Science ®Google Scholar
• Abd El-Wahab A, Wl-Adawi H, H SK. Towards Understanding The Hepatoprotective effect of grape seeds extract on Cholesterol-Fed rats. Aust J Basic Appl Sci. 2008;2(3):412–417.
   Google Scholar
• Pataki T, et al. Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr. 2002;75(5):894–9. doi: 10.1093/ajcn/75.5.894
   PubMed Web of Science ®Google Scholar
• Saad AA, Youssef MI, El-Shennawy LK. Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: the protective effect of grape seed proanthocyanidin extract. Food Chem Toxicol. 2009;47(7):1499–506. doi: 10.1016/j.fct.2009.03.043
   PubMed Web of Science ®Google Scholar
• Safwen K, Selima S, Mohamed E, Ferid L, Pascal C, Mohamed A, et al. Protective effect of grape seed and skin extract on cerebral ischemia in rat: implication of transition metals. Int J Stroke. 2015;10(3):415–24. doi: 10.1111/ijs.12391
   PubMed Web of Science ®Google Scholar
• Hwang IK, Yoo K-Y, Kim DS, Jeong Y-K, Kim JD, Shin H-K, et al. Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia. Life Sci. 2004;75(16):1989–2001. doi: 10.1016/j.lfs.2004.05.013
   PubMed Web of Science ®Google Scholar
• Devi A, Jolitha AB, Ishii N. Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats. Med Sci Monit. 2006;12(4):BR124-9.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Thomas P, Zhong J-H, Bi F-F, Kosaraju S, Pollard A, et al. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer’s disease mouse. Neurotox Res. 2009;15(1):3–14. doi: 10.1007/s12640-009-9000-x
   PubMed Web of Science ®Google Scholar
• Tripanichkul W, Jaroensuppaperch EO. Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice. Eur Rev Med Pharmacol Sci. 2013;17(10):1360–8.
   PubMed Web of Science ®Google Scholar
• Polazzi E, Mengoni I, Caprini M, Peña-Altamira E, Kurtys E, Monti B. Copper-zinc superoxide dismutase (SOD1) is released by microglial cells and confers neuroprotection against 6-OHDA neurotoxicity. Neurosignals. 2013;21(1-2):112–28. doi: 10.1159/000337115
   PubMedGoogle Scholar
• Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, Sadoul R, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol. 2001;65(2):135–72. doi: 10.1016/S0301-0082(01)00003-X
   PubMed Web of Science ®Google Scholar
• Lofrumento DD, Nicolardi G, Cianciulli A, Nuccio FD, Pesa VL, Carofiglio V, et al. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate Immun. 2014;20(3):249–60. doi: 10.1177/1753425913488429
   PubMed Web of Science ®Google Scholar
• Lin TK, Chen S-D, Chuang Y-C, Lin H-Y, Huang C-R, Chuang J-H, et al. Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci. 2014;15(1):1625–46. doi: 10.3390/ijms15011625
   PubMed Web of Science ®Google Scholar
• Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, et al. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res. 2010;1328:139–51. doi: 10.1016/j.brainres.2010.02.031
   PubMed Web of Science ®Google Scholar
• Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson’s disease in rats. Eur J Pharmacol. 2008;600(1-3):78–82. doi: 10.1016/j.ejphar.2008.10.005
   PubMed Web of Science ®Google Scholar
• Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP. Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med. 2012;52(8):1294–306. doi: 10.1016/j.freeradbiomed.2012.02.005
   PubMed Web of Science ®Google Scholar
• Teixeira MD, Souza CM, Menezes APF, Carmo MRS, Fonteles AA, Gurgel JP, et al. Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats. Pharmacol Biochem Behav. 2013;110:1–7. doi: 10.1016/j.pbb.2013.05.012
   PubMed Web of Science ®Google Scholar
• Ruan H, Yang Y, Zhu X, Wang X, Chen R. Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice. Neurosci Lett. 2009;450(2):152–7. doi: 10.1016/j.neulet.2008.12.003
   PubMed Web of Science ®Google Scholar
• Nobre Junior HV, Cunha GMA, Maia FD, Oliveira RA, Moraes MO, Rao VSN. Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. Comp Biochem Physiol C Toxicol Pharmacol. 2003;136(2):175–80. doi: 10.1016/S1532-0456(03)00198-4
   PubMed Web of Science ®Google Scholar
• Nie G, Jin C, Cao Y, Shen S, Zhao B. Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys. 2002;397(1):84–90. doi: 10.1006/abbi.2001.2636
   PubMed Web of Science ®Google Scholar
• Levites Y, Weinreb O, Maor G, Youdim MBH, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem. 2001;78(5):1073–82. doi: 10.1046/j.1471-4159.2001.00490.x
   PubMed Web of Science ®Google Scholar
• Bonilla-Ramirez L, Jimenez-Del-Rio M, Velez-Pardo C. Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism. Gene. 2013;512(2):355–63. doi: 10.1016/j.gene.2012.09.120
   PubMed Web of Science ®Google Scholar
• Bitu Pinto N, da Silva Alexandre B, Neves KRT, Silva AH, Leal LKAM, Viana GSB. Neuroprotective properties of the Standardized extract from Camellia sinensis (green Tea) and Its main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA model of Parkinson’s disease. Evid Based Complement Alternat Med. 2015;2015:161092. doi: 10.1155/2015/161092
   PubMed Web of Science ®Google Scholar
• Mansouri MT, Farbood Y, Sameri MJ, Sarkaki A, Naghizadeh B, Rafeirad M. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 2013;138(2-3):1028–33. doi: 10.1016/j.foodchem.2012.11.022
   PubMed Web of Science ®Google Scholar
• Lotharius J, Dugan LL, O’Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci. 1999;19(4):1284–93. doi: 10.1523/JNEUROSCI.19-04-01284.1999
   PubMed Web of Science ®Google Scholar
• Dodel RC, Du Y, Bales KR, Zaodong L, Carvey PM, Paul SM. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res Mol Brain Res. 1999;64(1):141–8. doi: 10.1016/S0169-328X(98)00318-0
   PubMedGoogle Scholar
• Rupinder SK, Gurpreet AK, Manjeet S. Cell suicide and caspases. Vascul Pharmacol. 2007;46(6):383–93. doi: 10.1016/j.vph.2007.01.006
   PubMed Web of Science ®Google Scholar
• Hartmann A, Hunot S, Michel PP, Muriel M-P, Vyas S, Faucheux BA, et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease. Proc Natl Acad Sci U S A. 2000;97(6):2875–80. doi: 10.1073/pnas.040556597
   PubMed Web of Science ®Google Scholar
• Zhen J, Qu Z, Fang H, Fu L, Wu Y, Wang H, et al. Effects of grape seed proanthocyanidin extract on pentylenetetrazole-induced kindling and associated cognitive impairment in rats. Int J Mol Med. 2014;34(2):391–8. doi: 10.3892/ijmm.2014.1796
   PubMed Web of Science ®Google Scholar
• Huang Z, de la Fuente-Fernandez R, Stoessl AJ. Etiology of Parkinson’s disease. Can J Neurol Sci. 2003;30 Suppl 1:S10–8. doi: 10.1017/S031716710000319X
   PubMed Web of Science ®Google Scholar
• Mecocci P, et al. Oxidative stress and dementia: new perspectives in AD pathogenesis. Aging (Milano). 1997;9(4 Suppl):51–2.
   PubMedGoogle Scholar
• Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem. 2001;8(7):721–38. doi: 10.2174/0929867013372922
   PubMed Web of Science ®Google Scholar
• Jenner P. Oxidative stress and Parkinson’s disease. Handb Clin Neurol. 2007;83:507–20. doi: 10.1016/S0072-9752(07)83024-7
   PubMedGoogle Scholar
• Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras Á, Muñoz-Patiño AM, Labandeira-Garcia JL. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease. J Neurochem. 2000;74(4):1605–12. doi: 10.1046/j.1471-4159.2000.0741605.x
   PubMed Web of Science ®Google Scholar
• Pelzer LE, Guardia T, Juarez AO, Guerreiro E. Acute and chronic antiinflammatory effects of plant flavonoids. Farmaco. 1998;53(6):421–4. doi: 10.1016/S0014-827X(98)00046-9
   PubMedGoogle Scholar
• Zhang F, Shi J-S, Zhou H, Wilson B, Hong J-S, Gao H-M. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol. 2010;78(3):466–77. doi: 10.1124/mol.110.064535
   PubMed Web of Science ®Google Scholar
• Hunot S, Brugg B, Ricard D, Michel PP, Muriel M-P, Ruberg M, et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A. 1997;94(14):7531–6. doi: 10.1073/pnas.94.14.7531
   PubMed Web of Science ®Google Scholar
• Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, et al. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A. 2007;104(47):18754–9. doi: 10.1073/pnas.0704908104
   PubMed Web of Science ®Google Scholar
• Cao S, Theodore S, Standaert DG. Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson’s disease. Mol Neurodegener. 2010;5:42. doi: 10.1186/1750-1326-5-42
   PubMed Web of Science ®Google Scholar
• Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002;9(3):625–36. doi: 10.1016/S1097-2765(02)00477-X
   PubMed Web of Science ®Google Scholar
• Chu AJ. Antagonism by bioactive polyphenols against inflammation: a systematic view. Inflamm Allergy Drug Targets. 2014;13(1):34–64. doi: 10.2174/1871528112666131119211002
   PubMedGoogle Scholar
• Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4:19. doi: 10.1186/s40035-015-0042-0
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, et al. Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med. 2011;27(2):195–203.
   PubMed Web of Science ®Google Scholar
• Stott SR, Barker RA. Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson’s disease. Eur J Neurosci. 2014;39(6):1042–56. doi: 10.1111/ejn.12459
   PubMed Web of Science ®Google Scholar
• Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience. 1994;59(2):401–15. doi: 10.1016/0306-4522(94)90605-X
   PubMed Web of Science ®Google Scholar
• Metz GA, Tse A, Ballermann M, Smith LK, Fouad K. The unilateral 6-OHDA rat model of Parkinson’s disease revisited: an electromyographic and behavioural analysis. Eur J Neurosci. 2005;22(3):735–44. doi: 10.1111/j.1460-9568.2005.04238.x
   PubMed Web of Science ®Google Scholar
• Perumal AS, Gopal VB, Tordzro WK, Cooper TB, Cadet JL. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bull. 1992;29(5):699–701. doi: 10.1016/0361-9230(92)90142-K
   PubMed Web of Science ®Google Scholar
• Chis IC, Ungureanu MI, Marton A, Simedrea R, Muresan A, Postescu I-D, et al. Antioxidant effects of a grape seed extract in a rat model of diabetes mellitus. Diab Vasc Dis Res. 2009;6(3):200–4. doi: 10.1177/1479164109336692
   PubMed Web of Science ®Google Scholar
• Arivazhagan P, Thilakavathy T, Panneerselvam C. Antioxidant lipoate and tissue antioxidants in aged rats. J Nutr Biochem. 2000;11(3):122–7. doi: 10.1016/S0955-2863(99)00079-0
   PubMed Web of Science ®Google Scholar
• Balu M, Sangeetha P, Haripriya D, Panneerselvam C. Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract. Neurosci Lett. 2005;383(3):295–300. doi: 10.1016/j.neulet.2005.04.042
   PubMed Web of Science ®Google Scholar
• Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004;56(4):532–9. doi: 10.1002/ana.20226
   PubMed Web of Science ®Google Scholar
• Marsden CD. Parkinson’s disease. Lancet. 1990;335(8695):948–52. doi: 10.1016/0140-6736(90)91006-V
   PubMed Web of Science ®Google Scholar
• Lang AE, Lozano AM. Parkinson’s disease. first of two parts. N Engl J Med. 1998;339(15):1044–53. doi: 10.1056/NEJM199810083391506
   PubMed Web of Science ®Google Scholar
• Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron. 2003;39(6):889–909. doi: 10.1016/S0896-6273(03)00568-3
   PubMed Web of Science ®Google Scholar
• Metzakopian E, Bouhali K, Alvarez-Saavedra M, Whitsett JA, Picketts DJ, Ang S-L. Genome-wide characterisation of Foxa1 binding sites reveals several mechanisms for regulating neuronal differentiation in midbrain dopamine cells. Development. 2015;142(7):1315–24. doi: 10.1242/dev.115808
   PubMed Web of Science ®Google Scholar
• Jaeger I, Arber C, Risner-Janiczek JR, Kuechler J, Pritzsche D, Chen I-C, et al. Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. Development. 2011;138(20):4363–74. doi: 10.1242/dev.066746
   PubMed Web of Science ®Google Scholar
• Pervin M, Hasnat M, Lee Y, Kim D, Jo J, Lim B. Antioxidant activity and acetylcholinesterase inhibition of grape skin anthocyanin (GSA). Molecules. 2014;19(7):9403–18. doi: 10.3390/molecules19079403
   PubMed Web of Science ®Google Scholar
• Burgess A, Vigneron S, Brioudes E, Labbé J-C, Lorca T, Castro A. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A. 2010;107(28):12564–9. doi: 10.1073/pnas.0914191107
   PubMed Web of Science ®Google Scholar